{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Severe+Acne+Vulgaris&page=4", "query": { "condition": "Severe Acne Vulgaris", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 87, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Severe+Acne+Vulgaris&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Severe+Acne+Vulgaris&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-12T20:15:14.681Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04092452", "title": "A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Inversa" ], "interventions": [ { "name": "PF-06650833", "type": "DRUG" }, { "name": "PF-06700841", "type": "DRUG" }, { "name": "PF-06826647", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 194, "start_date": "2019-12-02", "completion_date": "2022-01-10", "has_results": true, "last_update_posted_date": "2023-06-15", "last_synced_at": "2026-10-12T20:15:14.681Z", "location_count": 63, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Fremont, California + 42 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04092452" }, { "nct_id": "NCT04179175", "title": "Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hidradenitis Suppurativa" ], "interventions": [ { "name": "secukinumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 702, "start_date": "2020-03-18", "completion_date": "2026-07-15", "has_results": true, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-10-12T20:15:14.681Z", "location_count": 29, "location_summary": "Rogers, Arkansas • San Diego, California • Whittier, California + 22 more", "locations": [ { "city": "Rogers", "state": "Arkansas" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Whittier", "state": "California" }, { "city": "Coral Gables", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04179175" }, { "nct_id": "NCT04451330", "title": "A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Trifarotene cream", "type": "DRUG" }, { "name": "Doxycycline hyclate", "type": "DRUG" }, { "name": "Trifarotene Vehicle", "type": "DRUG" }, { "name": "Doxycycline Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 202, "start_date": "2020-07-29", "completion_date": "2021-04-26", "has_results": true, "last_update_posted_date": "2022-05-10", "last_synced_at": "2026-10-12T20:15:14.681Z", "location_count": 25, "location_summary": "Fort Smith, Arkansas • Hot Springs, Arkansas • Rogers, Arkansas + 21 more", "locations": [ { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Newport Beach", "state": "California" }, { "city": "Aventura", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04451330" }, { "nct_id": "NCT03573518", "title": "Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "BTX 1503", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Botanix Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "12 Years to 40 Years" }, "enrollment_count": 368, "start_date": "2018-06-26", "completion_date": "2019-09-05", "has_results": true, "last_update_posted_date": "2022-04-18", "last_synced_at": "2026-10-12T20:15:14.681Z", "location_count": 25, "location_summary": "Little Rock, Arkansas • Encino, California • Murrieta, California + 21 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Encino", "state": "California" }, { "city": "Murrieta", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Santa Monica", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03573518" }, { "nct_id": "NCT03497897", "title": "Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Inflammatory Acne" ], "interventions": [ { "name": "LYS006 20 mg", "type": "DRUG" }, { "name": "LYS006 2 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 66, "start_date": "2018-09-10", "completion_date": "2022-03-09", "has_results": true, "last_update_posted_date": "2023-08-31", "last_synced_at": "2026-10-12T20:15:14.681Z", "location_count": 7, "location_summary": "Fremont, California • Santa Monica, California • Hialeah, Florida + 4 more", "locations": [ { "city": "Fremont", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03497897" }, { "nct_id": "NCT02604680", "title": "A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "BLI1100-1", "type": "DRUG" }, { "name": "BLI1100-2", "type": "DRUG" }, { "name": "BLI1100-3", "type": "DRUG" }, { "name": "BLI1100-4", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Braintree Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "12 Years to 45 Years" }, "enrollment_count": 509, "start_date": "2015-10", "completion_date": "2016-06", "has_results": false, "last_update_posted_date": "2017-07-28", "last_synced_at": "2026-10-12T20:15:14.681Z", "location_count": 50, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Tucson, Arizona + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02604680" }, { "nct_id": "NCT04820673", "title": "Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Sarecycline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Almirall, S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": null, "sex": "ALL", "summary": "9 Years and older" }, "enrollment_count": 300, "start_date": "2021-03-09", "completion_date": "2022-05-04", "has_results": true, "last_update_posted_date": "2024-10-10", "last_synced_at": "2026-10-12T20:15:14.681Z", "location_count": 2, "location_summary": "Boston, Massachusetts • Brooklyn, New York", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Brooklyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04820673" }, { "nct_id": "NCT02815332", "title": "BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "BPX-01 1% Minocycline Topical Gel", "type": "DRUG" }, { "name": "BPX-01 2% Minocycline Topical Gel", "type": "DRUG" }, { "name": "BPX-01 Vehicle Topical Gel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioPharmX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "9 Years to 40 Years" }, "enrollment_count": 225, "start_date": "2016-08", "completion_date": "2017-03-24", "has_results": false, "last_update_posted_date": "2017-04-14", "last_synced_at": "2026-10-12T20:15:14.681Z", "location_count": 15, "location_summary": "Santa Monica, California • Coral Gables, Florida • Lake Mary, Florida + 12 more", "locations": [ { "city": "Santa Monica", "state": "California" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Lake Mary", "state": "Florida" }, { "city": "Newnan", "state": "Georgia" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT02815332" }, { "nct_id": "NCT00666900", "title": "A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Vulgaris" ], "interventions": [ { "name": "Low Strength IDP-107", "type": "DRUG" }, { "name": "High Strength IDP-107", "type": "DRUG" }, { "name": "Placebo Comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dow Pharmaceutical Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 366, "start_date": "2008-01", "completion_date": "2009-09", "has_results": false, "last_update_posted_date": "2012-02-20", "last_synced_at": "2026-10-12T20:15:14.681Z", "location_count": 25, "location_summary": "Hot Springs, Arkansas • Little Rock, Arkansas • San Diego, California + 22 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Vallejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00666900" }, { "nct_id": "NCT04019041", "title": "A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hidradenitis Suppurativa", "Acne Inversa", "Suppurative Hidradenitis" ], "interventions": [ { "name": "bermekimab", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 153, "start_date": "2019-09-16", "completion_date": "2020-11-17", "has_results": true, "last_update_posted_date": "2023-07-27", "last_synced_at": "2026-10-12T20:15:14.681Z", "location_count": 33, "location_summary": "Gilbert, Arizona • Huntington Beach, California • Los Angeles, California + 25 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04019041" } ] }